Natalie Kim

Najung “Natalie” Kim brings to the Office of Corporate Relations (OCR) expertise in strategic collaboration in life sciences and biotech industries including cell and gene therapy and AI/ML analytics. Kim comes to OCR from Adjuvant Partners where she has been serving as Senior Consultant, Strategic Partnering, working to connect industry, startups, and academic leaders in the cell and gene therapy sector. Before Adjuvant, Natalie worked at Ajinomoto where she was Manager, Research & Innovation Center facilitating collaborations on preclinical and clinical development of biologics, diagnostics, and cell therapy ancillary products in Asia, Europe, and North America. Prior to Ajinomoto, Kim was Business Development Manager at Medipost where she led strategic partnerships of mesenchymal stem cell therapeutics in the orthopedic and neurodegenerative applications. Kim also went through her postdoctoral training at the Wake Forest Institute for Regenerative Medicine as a Department of Defense Research Fellow working on translational gene therapy in tissue engineering programs.

Kim earned her B.S. Bioscience and Food Engineering at Handong Global University, her M.S. Medicine at Seoul National University in South Korea, and her Ph.D. Biomedical Engineering at the University of Iowa.